Research notes / Compounds
research article
The development of a selective pentapeptide
This five-residue research peptide has a documented development history. Its original assay comparisons are more informative than an unqualified description such as “selective.”
01
The original development paper
A 1998 European Journal of Endocrinology paper introduced the pentapeptide and compared its activity with other research compounds using laboratory and animal experiments. That paper provides a primary source for its development history.
The word selective depends on the comparisons and endpoints used by the investigators. Read which responses were measured, in which model, and against which reference compounds before repeating the term.
02
Five residues, with specific chemistry
A pentapeptide has five residues, but length alone does not identify it. The reference includes nonstandard residues and defined stereochemistry. A generic five-letter sequence can leave out chemically meaningful detail.
Use the linked structure in the product specifications when comparing identities. A different stereochemical form or residue substitution describes another molecule, even if most of the written name is similar.
03
The single compound and the blend
This page describes the individual catalog material. The paired blend has its own composition and total labeled amount. A paper on this single compound does not establish the properties of that blend.
For a reproducible record, save the source paper, exact chemical identity, catalog format and matching lot report. The report’s measured content and purity answer different questions and should be recorded separately.
A little more clarity
Questions, answered
Does five residues mean five standard amino acids?
Not necessarily. Nonstandard residues and stereochemistry are part of this reference identity.
Is the blend just another size of this product?
No. It contains another component and has its own formulation and documentation.
Follow the evidence
Sources & reading notes
Open the original record for its methods and limitations. The sources below do not certify the supplied product or its finished formulation.
- European Journal of Endocrinology · 1998 ↗
Original development and comparative assay paper.
Prepared by Prism Labs from the linked source records and public product documentation. Research context only; not a preparation protocol or a claim about outcomes. Send a source correction.